| Elkhorn Family Dental, Llc | |
|
211 North Main Street Boulder MT 59632-0512 | |
| (406) 225-4222 | |
| (406) 225-4222 |
| Full Name | Elkhorn Family Dental, Llc |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 211 North Main Street, Boulder, Montana |
| Authorized Official Name and Position | Charissa Foster Martin (OWNER) |
| Authorized Official Contact | 4062254222 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Elkhorn Family Dental, Llc Po Box 512 211 North Main Street Boulder MT 59632-0512 Ph: (406) 225-4222 | Elkhorn Family Dental, Llc 211 North Main Street Boulder MT 59632-0512 Ph: (406) 225-4222 |
| NPI Number | 1740546100 |
|---|---|
| Provider Enumeration Date | 04/10/2012 |
| Last Update Date | 04/10/2012 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740546100 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | 2386 (Montana) | Primary |
News Archive
New research published in the journal Viruses suggests recovering from a coronavirus disease 2019 (COVID-19) infection provides immunity against the B.1.1.7 (or UK) variant. The time when the previous infection took place and the variant involved in prior infection influenced cross-neutralization.
Every year, nearly two million people in the United States suffer traumatic brain injury (TBI), the leading cause of brain damage and permanent disabilities that include motor dysfunction, psychological disorders, and memory loss. Current rehabilitation programs help patients but often achieve limited success.
A new study has assessed the mortality risk of patients infected with the newly emerged UK variant (Lineage B.1.1.7) of SARS-CoV-2. The findings reveal that compared to the previously circulating SARS-CoV-2 variants, the UK variant significantly increases the risk of mortality in a relatively low-risk community population.
Excaliard Pharmaceuticals, Inc., today announced positive results from its Phase 2 clinical trial of EXC 001, a new chemical entity for reducing fibrosis. Results showed that EXC 001 treatment significantly reduced scar severity in subjects undergoing an elective abdominoplasty compared to placebo.
› Verified 2 days ago
Boulder Valley Dental Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 211 N Main St, Boulder, MT 59632 Phone: 406-225-4222 |